Dr Maribel Salas (Mexico / USA)
MD, DSc, MSc, FACP, FISPE, FISoP
Executive Medical Director, Bayer Pharmaceuticals | Adjunct Scholar, University of Pennsylvania and Rutgers University

Dr Maribel Salas is a global leader in pharmacoepidemiology and pharmacovigilance with over 20 years of experience spanning academia, government, and the pharmaceutical industry. She currently serves as Executive Medical Director and Global Safety Therapeutic Area Head in Oncology at Bayer Pharmaceuticals Inc., and as Adjunct Scholar at the University of Pennsylvania and Rutgers University. Her prior roles include Head of Global Epidemiology at Daiichi Sankyo and Regional Medical Director at AstraZeneca.

An accomplished researcher and educator, Dr Salas has held faculty positions at the University of Alabama at Birmingham, the Veterans Administration Hospital (USA), and the National Autonomous University of Mexico. She has mentored students worldwide and serves as Associate Editor of Pharmacoepidemiology and Drug Safety.

Within ISoP, Dr Salas has served as Advisory Board Member, Scientific Committee Chair (Montreal Annual Meeting), and Coordinator of Special Interest Groups. She has also held leadership positions in ISPE, ISPOR, and several U.S. government advisory committees.

Her vision for pharmacovigilance is for ISoP to lead globally as an unbiased scientific forum advancing education, research, and collaboration to promote patient safety and the rational use of medicines worldwide.